United States · FDA National Drug Code directory
Influenzinum
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0220-5106_3dfccd88-a92c-7eee-e063-6294a90adb28
- Product NDC
- 0220-5106
- Form
- PELLET
- Composition / generic term
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Labeler
- Boiron
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20250904
- Source listing expiry
- 20261231
Source-listed ingredients
- INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) — 6 [hp_C]/1
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) — 6 [hp_C]/1
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED) — 6 [hp_C]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 80 PELLET in 1 TUBE (0220-5106-41) · 0220-5106-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →